July 13, 2009 12:47 AM
- Text
Roche/Genentech Exodus No Longer Voluntary
(MoneyWatch)
Top executives from Genentech have been trickling away since Roche completed its acquisition of the biotech bellwether a few months ago, but reports indicate the departures are taking a less voluntary turn as the consolidation spreads from the ivory tower to the rank-and-file.
The San Francisco Chronicle reported the latest reductions on Friday, which apparently focused on folks in late stage drug development and corporate administration and affected less than one percent of Genentech's 8,250 Bay Area employees:
Rumor has it finance will be next -- CafePharma posters said Genentech's finance team is taking a trip to Nutley next week...
Layoffs photo by Fickr user snofla, CC2.0
Top executives from Genentech have been trickling away since Roche completed its acquisition of the biotech bellwether a few months ago, but reports indicate the departures are taking a less voluntary turn as the consolidation spreads from the ivory tower to the rank-and-file.The San Francisco Chronicle reported the latest reductions on Friday, which apparently focused on folks in late stage drug development and corporate administration and affected less than one percent of Genentech's 8,250 Bay Area employees:
"Roche has always communicated that it expected some redundancies in certain areas of the business," Genentech spokeswoman Caroline Pecquet said.And over on CafePharma, someone in Genentech marketing reported a "forced resignation" on Friday. According to another anonymous poster on Friday:
She could not say how many employees would ultimately be affected or how long it will take to complete the cuts.
Someone in my team was just let go being lazy and incompetenct [sic] and staying under the radar screen does not work anymore. The swiss are smarter than those californian typesMeanwhile IguanaBio reported Friday that Roche is axing its own folks in Nutley as well. According to their tip-off:
Heard from a friend-of-a-friend that last week Roche had the Nutley PD on campus for a round of layoffs (all part of the Genentech post-merger re-org). Said about one hundred people got a box, 10 minutes and an escort to their car.And the top brass continue to leave. Former Genentech CEO Arthur Levinson became chairman of Genentech's new board of directors in April; former product development head Susan Desmond-Hellmann was named chancellor of the University of California, San Francisco in May; and former CFO David Ebersman agreed a few weeks ago to become CFO at Facebook (H/T to FierceBiotech).
Rumor has it finance will be next -- CafePharma posters said Genentech's finance team is taking a trip to Nutley next week...
Layoffs photo by Fickr user snofla, CC2.0
Latest Now in MoneyWatch
- Insurers respond cautiously to contraceptive plan
- Judge: Legally, breastfeeding not related to pregnancy
- Budget deficit drops to $27 billion in January
- Why the Powerball Jackpot is part of my investment strategy
- Is the new VW Beetle diesel worth the money?
- Consumer sentiment highlights risks to recovery
- Valentine blues? 10 best cities to be single
- December trade deficit widens to $48.8 billion
- Alcatel-Lucent returns to profit in 2011
- 6 things never to say in a performance review
- $26B mortgage deal: Who gets the money?
- Friendly's CEO steps down
- Quarterly loss hits $3.3B at Postal Service
- Greeks rail against cuts as EU demands more
- 6 things you should never share on Facebook
- Make moves now to increase financial aid
- Valentine's Day: 9 places to save
Latest CBS News Headlines
on Facebook
on CBS News
- Exhibit looks back at 50 years of American fashion
- Man pleads guilty in NYC to harassing Ivanka Trump
- Mortenson asks judge to toss 'Three Cups' lawsuit
- Naomi Watts to star in Princess Diana biopic
on Facebook
- Adele sings a cappella for Anderson Cooper
- Josh Powell had "incestuous" images on his home computer, authorities say
- Adele sings a cappella for Anderson Cooper
on CBS News






